Quantified degree of eccentricity of aortic valve calcification predicts risk of paravalvular regurgitation and response to balloon post-dilation after self-expandable transcatheter aortic valve replacement.

Quantified degree of eccentricity of aortic valve calcification predicts risk of paravalvular regurgitation and response to balloon post-dilation after self-expandable transcatheter aortic valve replacement.

International Journal of Cardiology 2018; 259: 60-68.

Abstract

BACKGROUND:

Limited data exist regarding the impact of aortic valve calcification (AVC) eccentricity on the risk of paravalvular regurgitation (PVR) and response to balloon post-dilation (BPD) after transcatheter aortic valve replacement (TAVR). We investigated the prognostic value of AVC eccentricity in predicting the risk of PVR and response to BPD in patients undergoing TAVR.

METHODS:

We analyzed 85 patients with severe aortic stenosis who underwent self-expandable TAVR (43 women; 77.2±7.1years). AVC was quantified as the total amount of calcification (total AVC load) and as the eccentricity of calcium (EoC) using calcium volume scoring with contrast computed tomography angiography (CTA). The EoC was defined as the maximum absolute difference in calcium volume scores between 2 adjacent sectors (bi-partition method) or between sectors based on leaflets (leaflet-based method).

RESULTS:

Total AVC load and bi-partition EoC, but not leaflet-based EoC, were significant predictors for the occurrence of ≥moderate PVR, and bi-partition EoC had a better predictive value than total AVC load (area under the curve [AUC]=0.863 versus 0.760, p for difference=0.006). In multivariate analysis, bi-partition EoC was an independent predictor for the risk of ≥moderate PVR regardless of perimeter oversizing index. The greater bi-partition EoC was the only significant parameter to predict poor response to BPD (AUC=0.775, p=0.004).

CONCLUSION:

Pre-procedural assessment of AVC eccentricity using CTA as “bi-partition EoC” provides useful predictive information on the risk of significant PVR and response to BPD in patients undergoing TAVR with self-expandable valves.

Share:

More Posts

Diagram showing the components and placement of a Left Ventricular Assist Device (LVAD)

What Is an Artificial Heart Pump (LVAD) and Who Needs One?

For patients with advanced heart failure, medications alone may no longer be enough to help the heart pump blood effectively. A Left Ventricular Assist Device (LVAD), often referred to as an artificial heart pump, can help improve blood flow, relieve symptoms, and enhance quality of life. Learn how LVADs work, who may benefit from them, and what to expect before, during and after implantation.

Middle-aged Asian man clutching his chest, appearing to experience chest pain or symptoms of cardiac arrest.

Can Healthy Individuals Get Cardiac Arrest?

Even seemingly healthy individuals without known heart conditions can experience cardiac arrest. Recognising risk factors and adopting a heart-healthy lifestyle, including regular exercise, a balanced diet, avoiding smoking, limiting alcohol intake, managing stress and going for health screening regularly, can potentially reduce the risk.

Leaky tricuspid valve (tricuspid regurgitation) showing backward blood flow from the right ventricle into the right atrium

Minimally Invasive Treatment Options for Leaky Tricuspid Valve

A leaky tricuspid valve, also known as tricuspid regurgitation, is a heart valve condition that can cause swelling, breathlessness, fatigue, and worsening heart failure if left untreated. While open-heart surgery was once the only definitive treatment, advances in heart valve technology now allow selected patients to be treated using minimally invasive catheter-based procedures, including tricuspid transcatheter edge-to-edge repair, transcatheter tricuspid valve replacement, and caval valve implantation.

the connection between sleep problems and heart failure

The Hidden Connection between Sleep Problems and Heart Failure

Sleep problems are common among people with heart failure, and research shows the relationship goes both ways. Conditions such as obstructive sleep apnoea (OSA) and insomnia can worsen heart failure symptoms, while heart failure itself often leads to disturbed or poor-quality sleep. Recognising this two-way connection is an important step toward better symptom control and long-term heart health.

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy